For: |
Anderl F, Gerhard M. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i34/11939.htm |
Number | Citing Articles |
1 |
Sergio Rosales-Mendoza, Marlene Anahí Tello-Olea. Carrot Cells: A Pioneering Platform for Biopharmaceuticals Production. Molecular Biotechnology 2015; 57(3): 219 doi: 10.1007/s12033-014-9837-y
|
2 |
Weronika Gonciarz, Agnieszka Matusiak, Karolina Rudnicka, Tomasz Rechciński, Maciej Chałubiński, Elżbieta Czkwianianc, Marlena Broncel, Adrian Gajewski, Magdalena Chmiela. Autoantibodies to a specific peptide epitope of human Hsp60 (ATVLA) with homology to Helicobacter pylori HspB in H. pylori‐infected patients. APMIS 2019; 127(3): 139 doi: 10.1111/apm.12925
|
3 |
Karen Robinson, Darren P. Letley, Kazuyo Kaneko. Molecular Pathogenesis and Signal Transduction by Helicobacter pylori. Current Topics in Microbiology and Immunology 2017; 400: 1 doi: 10.1007/978-3-319-50520-6_1
|
4 |
Magdalena Chmiela, Zuzanna Karwowska, Weronika Gonciarz, Bujana Allushi, Paweł Stączek. Host pathogen interactions in <i>Helicobacter pylori</i> related gastric cancer. World Journal of Gastroenterology 2017; 23(9): 1521-1540 doi: 10.3748/wjg.v23.i9.1521
|
5 |
Yu. P. Uspenskiy, I. A. Gorbacheva, A. N. Suvorov, M. M. Galagudza, N. V. Baryshnikova, S. A. Bogdanova. IMMUNOLOGICAL CHANGES IN THE INVASION OF HELICOBACTER PYLORI: PROSPECTS FOR CREATING VACCINES. Translational Medicine 2019; 5(6): 31 doi: 10.18705/2311-4495-2018-5-6-31-40
|
6 |
Zeynab Kohandel, Tahereh Farkhondeh, Michael Aschner, Saeed Samarghandian. Molecular targets for the management of gastrointestinal cancer using melatonin, a natural endogenous body hormone. Biomedicine & Pharmacotherapy 2021; 140: 111782 doi: 10.1016/j.biopha.2021.111782
|
7 |
Amir Ghasemi, Nazanin Mohammad, Josef Mautner, Mehrnaz Taghipour Karsabet, Abolfazl Ardjmand, Rezvan Moniri. Immunization with recombinant FliD confers protection against Helicobacter pylori infection in mice. Molecular Immunology 2018; 94: 176 doi: 10.1016/j.molimm.2018.01.001
|
8 |
Doaa M. AlEraky, Hatem M. Abuohashish, Amr S. Bugshan, Maha M. Abdelsalam, Hussain A. AlHawaj, Taleb T. AlKhamis, Fatimah A. AlDossary, Nabras M. Alrayes, Yasser M. Ragab, Zeinab AbdelKhalek, Omneya M. Helmy, Mohammed A. Ramadan. Potential Antigenic Candidates for the Development of Peptide-Based Vaccines to Induce Immunization against Helicobacter pylori Infection in BALB/c Mice. International Journal of Molecular Sciences 2022; 23(21): 12824 doi: 10.3390/ijms232112824
|
9 |
Stephanie Longet, Aine Abautret-Daly, Christopher J. H. Davitt, Craig P. McEntee, Vincenzo Aversa, Monica Rosa, Ivan S. Coulter, Jan Holmgren, Sukanya Raghavan, Ed C. Lavelle. An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses. npj Vaccines 2019; 4(1) doi: 10.1038/s41541-019-0139-z
|
10 |
Iris Bosschem, Jagadeesh Bayry, Ellen De Bruyne, Kim Van Deun, Annemieke Smet, Griet Vercauteren, Richard Ducatelle, Freddy Haesebrouck, Bram Flahou, Luciana C. C. Leite. Effect of Different Adjuvants on Protection and Side-Effects Induced by Helicobacter suis Whole-Cell Lysate Vaccination. PLOS ONE 2015; 10(6): e0131364 doi: 10.1371/journal.pone.0131364
|
11 |
Zhenlong Xin, Shuai Jiang, Peng Jiang, Xiaolong Yan, Chongxi Fan, Shouyin Di, Guiling Wu, Yang Yang, Russel J. Reiter, Gang Ji. Melatonin as a treatment for gastrointestinal cancer: a review. Journal of Pineal Research 2015; 58(4): 375 doi: 10.1111/jpi.12227
|
12 |
Kimberly Venneman, Inge Huybrechts, Marc J. Gunter, Lieve Vandendaele, Rolando Herrero, Koen Van Herck. The epidemiology of Helicobacter pylori infection in Europe and the impact of lifestyle on its natural evolution toward stomach cancer after infection: A systematic review. Helicobacter 2018; 23(3) doi: 10.1111/hel.12483
|
13 |
Ying Zhang, Xiaoya Li, Baoen Shan, Hongtao Zhang, Lianmei Zhao. Perspectives from recent advances of Helicobacter pylori vaccines research. Helicobacter 2022; 27(6) doi: 10.1111/hel.12926
|
14 |
Yu. P. Uspenskiy, N. V. Baryshnikova, E. I. Ermolenko, A. N. Suvorov, A. V. Svarval. Anti-Helicobacter pylori vaccine: mith or reality?. Russian Journal of Infection and Immunity 2019; 9(3-4): 457 doi: 10.15789/2220-7619-2019-3-4-457-466
|
15 |
Zhenwen Zhou, Hui Dong, Yanmei Huang, Shuwen Yao, Bingshao Liang, Yongqiang Xie, Yan Long, Jialiang Mai, Sitang Gong. Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice. Journal of Medical Microbiology 2017; 66(1): 83 doi: 10.1099/jmm.0.000404
|
16 |
Rongguang Zhang, Guangcai Duan, Qingfeng Shi, Shuaiyin Chen, Qingtang Fan, Nan Sun, Yuanlin Xi. Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development. Biotechnology Letters 2016; 38(11): 1911 doi: 10.1007/s10529-016-2173-5
|
17 |
Amir Ghasemi, Nazanin Mohammad, Josef Mautner, Mehrnaz Taghipour Karsabet, Jafar Amani, Abolfazl Ardjmand, Zarichehr Vakili. Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection. Vaccine 2018; 36(34): 5124 doi: 10.1016/j.vaccine.2018.07.033
|
18 |
Nasrin Mirzaei, Farkhondeh Poursina, Sharareh Moghim, Niloufar Rashidi, Hajieh Ghasemian Safaei. The study ofH. pyloriputative candidate factors for single- and multi-component vaccine development. Critical Reviews in Microbiology 2017; 43(5): 631 doi: 10.1080/1040841X.2017.1291578
|
19 |
Mohammad Chehelgerdi, Abbas Doosti. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine. Journal of Nanobiotechnology 2020; 18(1) doi: 10.1186/s12951-020-00618-1
|
20 |
Ahmad Karkhah, Soheil Ebrahimpour, Maryam Rostamtabar, Veerendra Koppolu, Sorena Darvish, Veneela Krishna Rekha Vasigala, Majid Validi, Hamid Reza Nouri. Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases. Microbiological Research 2019; 218: 49 doi: 10.1016/j.micres.2018.09.011
|
21 |
T. N. Nikolaeva, V. V. Kozlov, E. A. Grigorieva, T. N. Kozhevnikova, A. V. Sanin, A. V. Pronin. Use of sodium polyprenylphosphate to correct changes in the immune response caused by Helicobacter pylori CagA proteins in the experiment. Experimental and Clinical Gastroenterology 2023; (11): 183 doi: 10.31146/1682-8658-ecg-207-11-183-190
|